BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.280
-0.220 (-8.80%)
At close: Mar 9, 2026, 4:00 PM EDT
2.310
+0.030 (1.32%)
After-hours: Mar 9, 2026, 7:33 PM EDT
BioNexus Gene Lab Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 5 | 9 | 165 | 365 | 236 | |
| Market Cap Growth | -12.29% | -46.33% | -94.33% | -54.75% | 54.35% | - | |
| Enterprise Value | 3 | 1 | 3 | 164 | 363 | 236 | |
| Last Close Price | 2.28 | 2.80 | 5.30 | 114.00 | 255.60 | 276.00 | |
| PE Ratio | - | - | - | - | 485.24 | 215.96 | |
| PS Ratio | 0.57 | 0.53 | 0.96 | 15.10 | 27.29 | 20.74 | |
| PB Ratio | 0.60 | 0.60 | 0.97 | 24.76 | 50.80 | 35.47 | |
| P/TBV Ratio | 0.79 | 0.60 | 0.97 | 24.76 | 50.80 | 35.47 | |
| P/FCF Ratio | - | - | - | 331.62 | 60792.56 | 1802.86 | |
| P/OCF Ratio | - | - | - | 299.07 | 39809.47 | 427.52 | |
| EV/Sales Ratio | 0.29 | 0.12 | 0.34 | 14.97 | 27.17 | 20.69 | |
| EV/EBITDA Ratio | - | - | - | - | 316.52 | 358.35 | |
| EV/EBIT Ratio | - | - | - | - | 343.88 | 415.74 | |
| EV/FCF Ratio | - | - | - | 328.74 | 60523.49 | 1798.18 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.07 | 0.19 | |
| Debt / FCF Ratio | - | - | - | 0.11 | 12.83 | 0.94 | |
| Net Debt / Equity Ratio | -0.39 | -0.50 | -0.60 | -0.31 | -0.28 | -0.40 | |
| Net Debt / EBITDA Ratio | 1.14 | 2.31 | 1.96 | 15.97 | -1.78 | -4.05 | |
| Net Debt / FCF Ratio | 0.96 | 1.69 | 2.93 | -4.14 | -341.22 | -20.33 | |
| Asset Turnover | 1.02 | 0.87 | 0.97 | 1.19 | 1.36 | 2.01 | |
| Inventory Turnover | 6.73 | 6.51 | 7.98 | 7.74 | 8.23 | 16.34 | |
| Quick Ratio | 6.81 | 3.10 | 4.24 | 2.52 | 2.39 | 2.02 | |
| Current Ratio | 8.30 | 3.81 | 4.93 | 3.01 | 3.07 | 2.37 | |
| Return on Equity (ROE) | -28.35% | -17.78% | -32.21% | -5.14% | 10.86% | 28.11% | |
| Return on Assets (ROA) | -16.43% | -10.86% | -18.85% | -1.50% | 6.70% | 6.25% | |
| Return on Invested Capital (ROIC) | -55.42% | -47.15% | -71.66% | -4.53% | 16.67% | 22.58% | |
| Return on Capital Employed (ROCE) | -35.20% | -22.40% | -31.10% | -3.30% | 14.60% | 8.40% | |
| Earnings Yield | -42.62% | -31.80% | -28.08% | -0.22% | 0.21% | 0.46% | |
| FCF Yield | -51.23% | -48.98% | -21.05% | 0.30% | 0.00% | 0.06% | |
| Buyback Yield / Dilution | -1.15% | -12.24% | -10.17% | -0.99% | -66.36% | -19.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.